In COAD, NAT1 has been found to be enriched in the caffeine metabolism pathway (Liu et al., 2015), and inhibition of its expression by curcumin has been demonstrated in COAD cells (Chen et al., 2003). The gene discussed is NAT1; the disease is colon adenocarcinoma.